Marshall Wace Asia’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-33,243
Closed -$1.3M 155
2021
Q2
$1.3M Buy
33,243
+23,516
+242% +$679K 0.03% 111
2021
Q1
$275K Buy
+9,727
New +$310K 0.01% 129
2020
Q3
Sell
-23,139
Closed -$638K 148
2020
Q2
$638K Buy
23,139
+22,597
+4,169% +$490K 0.01% 97
2020
Q1
$10K Buy
+542
New +$13.1K ﹤0.01% 109
2019
Q4
Sell
-3,976
Closed -$71K 158
2019
Q3
$71K Buy
+3,976
New +$82.8K ﹤0.01% 134
2018
Q3
Sell
-10,620
Closed -$320K 103
2018
Q2
$320K Buy
+10,620
New +$337K 0.01% 82

Other funds holding HCM

Marshall Wace Asia's HCM Position: Q3 2021 in Review

Marshall Wace Asia sold out of HUTCHMED (HCM) in Q3 2021, closing a stake of 33,243 shares — an estimated $1.3M sold.

Marshall Wace Asia first reported a position in HCM in Q2 2018 and held it in 6 quarters. The position peaked at $1.3M in Q2 2021. 144 funds tracked by Wall St. Rank hold HCM as of Q3 2021.

  • Marshall Wace Asia reported no remaining HUTCHMED position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace Asia sold 33,243 HUTCHMED shares in Q3 2021, an estimated $1.3M.
  • Marshall Wace Asia first reported a position in HUTCHMED in Q2 2018 and held it in 6 quarters.
  • Marshall Wace Asia's HUTCHMED position peaked at $1.3M in Q2 2021.
  • 144 funds tracked by Wall St. Rank held HUTCHMED as of Q3 2021.

Based on Marshall Wace Asia's 13F filing for Q3 2021, filed 15 Nov 2021.